Download presentation
Presentation is loading. Please wait.
1
Thrombosis, Cancer, and NOACs
3
Program Goals
4
Cancer-Associated VTE
5
Oral Anticoagulants Are Preferred
6
Patient Persistence With Anticoagulation: LMWH vs Oral Agents
7
Hokusai VTE-Cancer Study: Design
8
Hokusai VTE-Cancer Study: Outcomes
9
Hokusai VTE-Cancer Study: Results
10
Hokusai VTE-Cancer Study: Results (cont)
11
Hokusai VTE-Cancer Study: Results (cont)
12
SELECT-D Trial: Design
13
SELECT-D Trial: Primary Endpoint
14
SELECT-D Trial: Results
15
Can Oral Anticoagulation Replace LMWH?
16
Patient Adherence
17
GI Bleeding
18
Patient Preferences
19
Treatment vs Prophylaxis
20
CASSINI Trial: Design
21
AVERT Trial: Design
22
Summary
23
Abbreviations
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.